SlideShare a Scribd company logo
Dr ABHINAND
MALABAR DENTAL COLLEGE
NONSTEROIDAL ANTI-
INFLAMMATORY DRUGS
CONTENT
 Introduction
 Classification
 Mechanism of action
 Ibuprofen
 Acetyl salicylic acid
 Pyrazolone derivatives
 Other non selective cox 2 inhibitors
 Cox 2 selective inhibitors
INTRODUCTION
 Most widely used therapeutic agent in world wide
 They are also called 1.aspirin like analgesics
2.non narcotics
3.non opioids
 Analgesics
 Antipyretics
 Anti-inflammatory actions
 Uricosuric properties
CLASSIFICATION
1. Non seletive COX inhibitors
 Salicylic acid derivatives
( aspirin , sodium salicylate ,diflunisal)
 Para-aminophenol derivatives
( paracetamol)
 Pyrazolone derivatives
(phenylbutazone)
 Indole acetic acid derivatives
(Indomethacin, sulindac)
 Arylacetic acid derivatives
(Diclofenac, aciclofenac, ketorolac)
 Propoinic acid derivatives
(ibuprofen,fenoprofen,naproxen,flurbiprofen)
 Anthranilic acids(fenamate)
(flufenamic acid,mefenamic acid,enfenamic
acid)
 Oxicams
(piroxicam ,tenoxicam)
 Alkanones
(nabumetone)
2. Selective cox2 inhibitors
(celocoxib,rofecoxib)
3.Preferential cox-2inhibitors
(nimesulide,meloxicam)
4 nsaids that do not inhibit PG synthesis
(metamizol ,nefopam)
MODE OF ACTION
 During inflammation , arachidonic acid liberated from
membarane phospholipids is converted to PGs
catalysed by enzyme COX
 PGs sensitize nerve endings and produce hyperalgia
by mediators like bradykinin and histamine
 NSAIDs inhibit PG synthesis by blocking the enzyme
cyclo-oxygenase
 Two types COX enzyme ,COX1 and COX2
 COX1 seen in normal cell to mainatin
hemostasis(costitutive)
 COX 2 induced by inflammatory cell(inducible)
NON SELECTIVE COX
INHIBITORS
SALICYLATES
 Salts of salicylic acid
 Aspirin is taken as the prototype
PHARMOCOLOGICAL ACTION
1. Analgesia-(300-600mg/day)
 Relief pain in inflammatory orgin
 Pain orginating from integumentary structure
like muscle,bone joints,muscle,and pain in
connective tissue is releived
 Relif without euphoria and hypnosis, so less
chance to developmnt of dependence and
tolerance
2.Antipyretics-(300-600mg/day)
 in the presence of fever salicylates bring down
the temperature to normal.
 In fever ,pyrogen increase the PGs synthesis in
hypothalamus and disturbs the thermostat
 Aspirin inhibit PGs synthesis and reset the
temperature.
 Increase the sweating and cutaneous
vasodialation assist the antipyretic action
3.Anti-inflammatory action
 At higher doses of 4-6g/day
 It reduces the inflammatory signs like
tenderness ,swelling ,erythema , and pain
 But actually disease is progressing
 In addition,Aspirin interfere with the formation
of chemical mediators of kallilerin system.
4.Respiration
 In therapeutic doses,it increase the consumption of
O2 by skeltal muscles.→↑co2
 It stimulates the respiratory center-→co2 washed out
and leads to respiratory alkalosis and increase in
pH→compensated by excretion of HCO3→known as
compensated respiratory alkalosis
 With toxic dose,direct stimulation of centres -
Depression of respiratory center& cardiovascular
centre→↑bp,respiratory acidosis,no compensations
&metabbolic acidosis also-so called uncompensated
respiratory acidosis
 Renal failure
5.acid-base &electrolyte balance
 In anti inflammatory dose ,it produce significant
respiratory stimulation-co2 washed out resulting
in respiratory alkalosis,pH become alkaline.
 It compensated by secretion of HCO3+
 In toxic doses produce respiratory acidosis
 Effects accompanied by dehydration
6.Metabolic effect
 Enhance the cellular metabolism due to
uncoupling of oxidative phosphyration
 More of o2 is used more co2 is produced ,leading
to incresed heat production
7.GIT
Aspirin blocks the PGs in stomach that leads to
increase the hcl in stomach
 Also salicylic acid increase HCl directly. This
leads to peptic ulcer.
 Also it affect CTZ and induce emesis
ADVERSE EFFECT
1. GIT. Nausea ,epigastric
distress,vomitting,erosive gastrirtis,peptic
ulcer,increased occult blood loss in stools
2. CNS-headache,diziness
3. ALLERGIC REACTION
4. RESPIRATORY SYSTEM
5. HEMOLYSIS
6. NEPHROTOXICITY
7. REYE’S SYNDROME
8. PREGNANCY AND INFANCY
9. SALICYLISM
ACUTE SALICYLATE
INTOXICATION
 Poisoning may be accidental or suicidal
 More common in childrens
 15-30 g is the fatal dose
 Symptoms and signs-
dehydration,hyoerpyrexia,GI
irritation,vomitting,acid base
imbalance,restlessness,deliriumhalucination,meta
bolic acidosis,tremors,convulsions,coma,death
due to resoiratory failure
 TREATMENT-
 Gastric lavage to eliminate unabsrobed drugs
 Iv fluid to correct the acid base imbalance and
dehydration
 T is brouht down by external cooling with alcohole
or cold water sponges
 If hemorragic complications are seen ,blood
transfusion and vit K are needed
 In severe cases,forced alkaline diuresis with
NaHCO3 and diuretic like frusemides is given
along with iv fluid.
PRECAUTION
&CONTRAINDICATION
1. Peptic ulcer
2. Sensitive pt.
3. Children suffering from influenza &chickenpox
4. Chronic liver disease
5. Diabetics
6. Pregnancy-delayed labour,premature closure
of ductus arterioles,bleeding
7. G6PD deficiency
INTERACTION
 Aspirin competes for pp sites and displacesdrug
molecules resulting in toxicity like
warfarin,heparin,naproxen,phenytoin
 Inhibit the tubular scretion of uric acid and
antogonizes the actions of uricosuric agent
USES
1. As analgesics(300-400 mg/day in every 6-8 hrs)
2. Fever
3. For anti inflamatory conditions(4-6g/day)
4. Acute rheumatic fever(4-6g/day in 4-6 devided
intrvl)
5. Rheumatoid arthritis
6. To delay labour
7. Prevention of colon cancer
8. PDA
9. Bartter s syndrom
10. Cataract
11. Osteoarthritis
PARA-AMINOPHENOL
DERIVATIVES
 Eg;-paracetamol(acetoaminophen)
 It has analgesics,antipyreticand weak anti-
inflamatory properties
 Uses-analgesics in painful condition like
toothache,headache,myalgia
 Used in chronic pulpitis,periodontal
abcess,postextraction –used as combination
 Adverse effect is hepatotoxic
PYRAZOLONE DERIVATIVES
 Eg;-phenylbutazone ,azapropazone,metamizol
phenylbutazone
 Good antiinflamatory and uricosuric agent
 More toxic than aspirin
 Uses are rheumatoid arthritis ,ankylosing
spondylatis, gout,muskuloskeltal disorder
 DOSE-100-200mg
INDOLE DERIVATIVES
 Eg:-indomethacine,sulindac,etodolac
 It is a potent antiinflamatory agent ,antipyretic,and
good analgesics
 USES-1.rheumatoid arthrits
2.gout
3.closure of PDA
4.eye drops in inflamatoin
5.mouth rinsers in gingival inflammation
 Side effects-CNS,GIT,and hyoersensitive reaction
ARYLACETIC ACID
DERIVATIVES
Eg;-diclofenac,aciclofenac,keterolac
 Aciclofenac-long acting ,more gastric
friendly,COX2 selective
 Used for acute musculoskeltal pain,painful dental
lesions,post operatively for relief pain
 Dose-100mg BD
 Diclofenac-analgesics,antipyretics,and anti-
inflamatory agent
 Dose is 50 mg BD and gel are available for
topical applications
PROPONOIC ACID
DERIVATIVES
Eg:-Ibuprofen,naproxen,carprofen
Ibuprofen
 Analgesics,antipyretics,anti-inflamtory action
 Acts by inhibits the PGs synthesis
 Uses 1.Contol post surgical pain,
2.in fever
3.impacted tooth removal
4.gout.
 Side effect -nausea ,vomitting,fluid
retention,hypertensive reactionand gastric distress
 Dose -400-800 mg TDS
 NAPROXEN
 Mode of action-NSAIDs reduces PGs activity.
 Anti-inflamatory and antipyretic poperty
 Contraindication-allergic pts.
 Precaution-pts. With decreased renal function
and liver function,heart failure or diuretic therapy
can be risk for liver dysfunctionfluid retention
while taking naproxen
ANTHRANILIC ACIDS
(FENAMATES)
Eg;-flufenamic acid,mefenamic acid enfenamic acid
 They are anagesics,antipyretic,antiinflamatory
drugs
 Contraindicated in children
 They are not generally preferred
 Diarrhea is common side effect
 Mefenamic acid is used in dysmenorrhea(250-
500mg TDS)
 Mefenamic acid exert peripheral and central
analgesic action
OXICAMS
 EG;-piroxicam ,meloxicam
 Piroxicam- Reversible cox inhibitor
 Dose 20 mg OD
 Used for rheumatoid arthritis ,osteoarthritis,painful
dental lesions
 Meloxicam-similar to piroxicam
 Dose-7.5-15 mg once daily
ALKANONES
Eg;-nabumetone
 It is antiinflamatory agent with significant efficacy
in rheumatoid arthritis and osteoarthritis
 Less uricogenic proprty
 Used in rheumatoid and osteoarthritis
SELECTIVE COX2
INHIBITORS
 Eg;-celocoxib,rofecoxib,valdecoxib,etoricoxib
 Celecoxib 100-200mg
 Rofecoxib 12.5-25mg OD
 Valdecoxib 20mg BD
 Low uricogenic potential
 Pedal edema &rise in BP occurs as result of salt
and water retention due to the inhibition of
consitutive COX2
 Use for long term analgesics in chronic pain
PREFERENTIAL COX2
INHIBITORS
 Eg;-nimesulide
 Used for short lasting painful conditions-sinusitis
,dental surgery ,backache , dysmenorrhea
 Side effect-fuminant hepatitis
-bronchospasm
 Dose-50-100mg BD
NSAIDS THAT DONOT INHIBIT
PGs SYNTHESIS
 Eg;-metamizol
 analgin.,novalgin
 Potent analgesics and antipyretics
 Dose-500mg 3-4 times a day
 Not recommended in childresns upto 6 years
REFERENCE
 TEXT BOOK OF PHARMOCOLOGY
-TRIPATI
 TEXT BOOK OF ORAL AND MAXILLOFACIAL
SURGERY
- SM BALAJI
TEXT BOOK OF DENTAL PHARMACOLOGY
- PADMAJA
UDAYAKUMAR
Nonsteroidal anti inflammatory drugs

More Related Content

What's hot

Main bleach/endodontic courses
Main bleach/endodontic coursesMain bleach/endodontic courses
Main bleach/endodontic courses
Indian dental academy
 
Impression materials
Impression materialsImpression materials
Impression materials
drmadhubilla
 
Zinc phosphate
Zinc phosphateZinc phosphate
Zinc phosphate
U1Yuvansai
 
Biocomptability of dental materials seminar
Biocomptability of dental materials seminarBiocomptability of dental materials seminar
Biocomptability of dental materials seminar
Mayank Aggarwal
 
MCQs on Dental materials - Amalgams
MCQs on Dental materials - AmalgamsMCQs on Dental materials - Amalgams
MCQs on Dental materials - Amalgams
Raman Dhungel
 
Casting gold alloys
Casting gold alloysCasting gold alloys
Casting gold alloys
Vyshak John
 
Alginate-Irreversible Hydrocolloid
Alginate-Irreversible HydrocolloidAlginate-Irreversible Hydrocolloid
Alginate-Irreversible HydrocolloidAmeet Agrawal
 
Obtudent, mummifying agents and disclosing agent
Obtudent, mummifying agents and disclosing agentObtudent, mummifying agents and disclosing agent
Obtudent, mummifying agents and disclosing agent
bibi umeza
 
Finishing and polishing
Finishing and polishingFinishing and polishing
Finishing and polishing
Vasundhara naik
 
89362217 pharmacology-in-endodontics
89362217 pharmacology-in-endodontics89362217 pharmacology-in-endodontics
89362217 pharmacology-in-endodontics
Krishna Jaiswal
 
Pulp protection in operative dentistry
Pulp protection in operative dentistry Pulp protection in operative dentistry
Pulp protection in operative dentistry
Nivedha Tina
 
advances in resin composites dental material
 advances in resin composites dental material advances in resin composites dental material
advances in resin composites dental material
Dr-Faisal Al-Qahtani
 
artificial denture teeth dental material
artificial denture teeth dental materialartificial denture teeth dental material
artificial denture teeth dental material
Dr-Faisal Al-Qahtani
 
Ozone Therapy in Dentistry
Ozone Therapy in DentistryOzone Therapy in Dentistry
Ozone Therapy in Dentistry
Dr Tridib Goswami
 
Intracanal Medicaments in Endodontics - Summarized
Intracanal Medicaments in Endodontics - SummarizedIntracanal Medicaments in Endodontics - Summarized
Intracanal Medicaments in Endodontics - Summarized
Iraqi Dental Academy
 
Local Anesthetics in Dentistry
Local Anesthetics in DentistryLocal Anesthetics in Dentistry
Local Anesthetics in DentistryMedicineAndFamily
 
class iv direct composite
class iv direct compositeclass iv direct composite
class iv direct composite
ddert
 

What's hot (20)

Management of dental caries
Management of dental cariesManagement of dental caries
Management of dental caries
 
Main bleach/endodontic courses
Main bleach/endodontic coursesMain bleach/endodontic courses
Main bleach/endodontic courses
 
Impression materials
Impression materialsImpression materials
Impression materials
 
Zinc phosphate
Zinc phosphateZinc phosphate
Zinc phosphate
 
Biocomptability of dental materials seminar
Biocomptability of dental materials seminarBiocomptability of dental materials seminar
Biocomptability of dental materials seminar
 
MCQs on Dental materials - Amalgams
MCQs on Dental materials - AmalgamsMCQs on Dental materials - Amalgams
MCQs on Dental materials - Amalgams
 
Casting gold alloys
Casting gold alloysCasting gold alloys
Casting gold alloys
 
Alginate-Irreversible Hydrocolloid
Alginate-Irreversible HydrocolloidAlginate-Irreversible Hydrocolloid
Alginate-Irreversible Hydrocolloid
 
Obtudent, mummifying agents and disclosing agent
Obtudent, mummifying agents and disclosing agentObtudent, mummifying agents and disclosing agent
Obtudent, mummifying agents and disclosing agent
 
Finishing and polishing
Finishing and polishingFinishing and polishing
Finishing and polishing
 
89362217 pharmacology-in-endodontics
89362217 pharmacology-in-endodontics89362217 pharmacology-in-endodontics
89362217 pharmacology-in-endodontics
 
Pulp protection in operative dentistry
Pulp protection in operative dentistry Pulp protection in operative dentistry
Pulp protection in operative dentistry
 
advances in resin composites dental material
 advances in resin composites dental material advances in resin composites dental material
advances in resin composites dental material
 
artificial denture teeth dental material
artificial denture teeth dental materialartificial denture teeth dental material
artificial denture teeth dental material
 
Dental Cement
Dental CementDental Cement
Dental Cement
 
Ozone Therapy in Dentistry
Ozone Therapy in DentistryOzone Therapy in Dentistry
Ozone Therapy in Dentistry
 
Intracanal Medicaments in Endodontics - Summarized
Intracanal Medicaments in Endodontics - SummarizedIntracanal Medicaments in Endodontics - Summarized
Intracanal Medicaments in Endodontics - Summarized
 
Local Anesthetics in Dentistry
Local Anesthetics in DentistryLocal Anesthetics in Dentistry
Local Anesthetics in Dentistry
 
class iv direct composite
class iv direct compositeclass iv direct composite
class iv direct composite
 
Impression materials
Impression materialsImpression materials
Impression materials
 

Similar to Nonsteroidal anti inflammatory drugs

Non Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory DrugsNon Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory Drugs
Dr Rayan Malick
 
Prescibing analgesics
Prescibing analgesicsPrescibing analgesics
Prescibing analgesicsraj kumar
 
NSAIDS -Unit III CHEMISTRY ,COLOGY,NOTES
NSAIDS -Unit III CHEMISTRY ,COLOGY,NOTESNSAIDS -Unit III CHEMISTRY ,COLOGY,NOTES
NSAIDS -Unit III CHEMISTRY ,COLOGY,NOTES
Affrin Shaik
 
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
HimanshuJoshi255
 
Nsaids hwuegi1
Nsaids hwuegi1Nsaids hwuegi1
Nsaids hwuegi1hwuegi
 
Non steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugsNon steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugsNimra Iqbal
 
5) NON STEROIDAL ANTI INFLAMMATORY DRUGS.ppt
5) NON STEROIDAL ANTI INFLAMMATORY DRUGS.ppt5) NON STEROIDAL ANTI INFLAMMATORY DRUGS.ppt
5) NON STEROIDAL ANTI INFLAMMATORY DRUGS.ppt
VarshaPatel72
 
Non Steroidal Anti-Inflammatory Drugs
Non Steroidal Anti-Inflammatory DrugsNon Steroidal Anti-Inflammatory Drugs
Non Steroidal Anti-Inflammatory Drugs
Hri M
 
Analgesics.pptx
Analgesics.pptxAnalgesics.pptx
Analgesics.pptx
eyobkaseye
 
NON STEROIDAL & ANTI‐INFLAMMATORY DRUGS
NON STEROIDAL & ANTI‐INFLAMMATORY DRUGS NON STEROIDAL & ANTI‐INFLAMMATORY DRUGS
NON STEROIDAL & ANTI‐INFLAMMATORY DRUGS
Jai Narain Vyas University Jodhpur Rajasthan India 342003
 
Asprin pptx
Asprin pptxAsprin pptx
NSAID's
NSAID's NSAID's
Analgesic.pptx
Analgesic.pptxAnalgesic.pptx
Analgesic.pptx
DentalYoutube
 
NSAIDS(NON-STEROIDAL ANTI INFLAMMATORY DRUGS)
NSAIDS(NON-STEROIDAL ANTI INFLAMMATORY DRUGS)NSAIDS(NON-STEROIDAL ANTI INFLAMMATORY DRUGS)
NSAIDS(NON-STEROIDAL ANTI INFLAMMATORY DRUGS)
marymelna1
 
opioid and non-opioid analgesics.ppt
opioid and non-opioid analgesics.pptopioid and non-opioid analgesics.ppt
opioid and non-opioid analgesics.ppt
uvraj721
 
Antipyretic, analgesic
Antipyretic,  analgesicAntipyretic,  analgesic
Antipyretic, analgesic
MrunalAkre
 
NSAID PHARMACOLOGY....................................
NSAID PHARMACOLOGY....................................NSAID PHARMACOLOGY....................................
NSAID PHARMACOLOGY....................................
rameezmansuri5
 
Diuretic and Urinary alkalizes-Dr.Jibachha Sah,M.V.Sc
Diuretic and Urinary alkalizes-Dr.Jibachha Sah,M.V.ScDiuretic and Urinary alkalizes-Dr.Jibachha Sah,M.V.Sc
Diuretic and Urinary alkalizes-Dr.Jibachha Sah,M.V.Sc
Dr. Jibachha Sah
 
NSAID'S --ASPIRIN
NSAID'S --ASPIRINNSAID'S --ASPIRIN
NSAID'S --ASPIRIN
Heena Parveen
 

Similar to Nonsteroidal anti inflammatory drugs (20)

Non Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory DrugsNon Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory Drugs
 
Prescibing analgesics
Prescibing analgesicsPrescibing analgesics
Prescibing analgesics
 
NSAIDS -Unit III CHEMISTRY ,COLOGY,NOTES
NSAIDS -Unit III CHEMISTRY ,COLOGY,NOTESNSAIDS -Unit III CHEMISTRY ,COLOGY,NOTES
NSAIDS -Unit III CHEMISTRY ,COLOGY,NOTES
 
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
 
Nsaids hwuegi1
Nsaids hwuegi1Nsaids hwuegi1
Nsaids hwuegi1
 
Non steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugsNon steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugs
 
5) NON STEROIDAL ANTI INFLAMMATORY DRUGS.ppt
5) NON STEROIDAL ANTI INFLAMMATORY DRUGS.ppt5) NON STEROIDAL ANTI INFLAMMATORY DRUGS.ppt
5) NON STEROIDAL ANTI INFLAMMATORY DRUGS.ppt
 
Non Steroidal Anti-Inflammatory Drugs
Non Steroidal Anti-Inflammatory DrugsNon Steroidal Anti-Inflammatory Drugs
Non Steroidal Anti-Inflammatory Drugs
 
Analgesics.pptx
Analgesics.pptxAnalgesics.pptx
Analgesics.pptx
 
NON STEROIDAL & ANTI‐INFLAMMATORY DRUGS
NON STEROIDAL & ANTI‐INFLAMMATORY DRUGS NON STEROIDAL & ANTI‐INFLAMMATORY DRUGS
NON STEROIDAL & ANTI‐INFLAMMATORY DRUGS
 
Asprin pptx
Asprin pptxAsprin pptx
Asprin pptx
 
NSAID's
NSAID's NSAID's
NSAID's
 
Analgesic.pptx
Analgesic.pptxAnalgesic.pptx
Analgesic.pptx
 
NSAIDS(NON-STEROIDAL ANTI INFLAMMATORY DRUGS)
NSAIDS(NON-STEROIDAL ANTI INFLAMMATORY DRUGS)NSAIDS(NON-STEROIDAL ANTI INFLAMMATORY DRUGS)
NSAIDS(NON-STEROIDAL ANTI INFLAMMATORY DRUGS)
 
opioid and non-opioid analgesics.ppt
opioid and non-opioid analgesics.pptopioid and non-opioid analgesics.ppt
opioid and non-opioid analgesics.ppt
 
Antipyretic, analgesic
Antipyretic,  analgesicAntipyretic,  analgesic
Antipyretic, analgesic
 
Nsaial
NsaialNsaial
Nsaial
 
NSAID PHARMACOLOGY....................................
NSAID PHARMACOLOGY....................................NSAID PHARMACOLOGY....................................
NSAID PHARMACOLOGY....................................
 
Diuretic and Urinary alkalizes-Dr.Jibachha Sah,M.V.Sc
Diuretic and Urinary alkalizes-Dr.Jibachha Sah,M.V.ScDiuretic and Urinary alkalizes-Dr.Jibachha Sah,M.V.Sc
Diuretic and Urinary alkalizes-Dr.Jibachha Sah,M.V.Sc
 
NSAID'S --ASPIRIN
NSAID'S --ASPIRINNSAID'S --ASPIRIN
NSAID'S --ASPIRIN
 

Recently uploaded

How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Wasim Ak
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
gb193092
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 

Recently uploaded (20)

How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 

Nonsteroidal anti inflammatory drugs

  • 1. Dr ABHINAND MALABAR DENTAL COLLEGE NONSTEROIDAL ANTI- INFLAMMATORY DRUGS
  • 2. CONTENT  Introduction  Classification  Mechanism of action  Ibuprofen  Acetyl salicylic acid  Pyrazolone derivatives  Other non selective cox 2 inhibitors  Cox 2 selective inhibitors
  • 3. INTRODUCTION  Most widely used therapeutic agent in world wide  They are also called 1.aspirin like analgesics 2.non narcotics 3.non opioids  Analgesics  Antipyretics  Anti-inflammatory actions  Uricosuric properties
  • 4. CLASSIFICATION 1. Non seletive COX inhibitors  Salicylic acid derivatives ( aspirin , sodium salicylate ,diflunisal)  Para-aminophenol derivatives ( paracetamol)  Pyrazolone derivatives (phenylbutazone)  Indole acetic acid derivatives (Indomethacin, sulindac)  Arylacetic acid derivatives (Diclofenac, aciclofenac, ketorolac)
  • 5.  Propoinic acid derivatives (ibuprofen,fenoprofen,naproxen,flurbiprofen)  Anthranilic acids(fenamate) (flufenamic acid,mefenamic acid,enfenamic acid)  Oxicams (piroxicam ,tenoxicam)  Alkanones (nabumetone)
  • 6. 2. Selective cox2 inhibitors (celocoxib,rofecoxib) 3.Preferential cox-2inhibitors (nimesulide,meloxicam) 4 nsaids that do not inhibit PG synthesis (metamizol ,nefopam)
  • 7. MODE OF ACTION  During inflammation , arachidonic acid liberated from membarane phospholipids is converted to PGs catalysed by enzyme COX  PGs sensitize nerve endings and produce hyperalgia by mediators like bradykinin and histamine  NSAIDs inhibit PG synthesis by blocking the enzyme cyclo-oxygenase  Two types COX enzyme ,COX1 and COX2  COX1 seen in normal cell to mainatin hemostasis(costitutive)  COX 2 induced by inflammatory cell(inducible)
  • 8.
  • 10. SALICYLATES  Salts of salicylic acid  Aspirin is taken as the prototype PHARMOCOLOGICAL ACTION 1. Analgesia-(300-600mg/day)  Relief pain in inflammatory orgin  Pain orginating from integumentary structure like muscle,bone joints,muscle,and pain in connective tissue is releived  Relif without euphoria and hypnosis, so less chance to developmnt of dependence and tolerance
  • 11. 2.Antipyretics-(300-600mg/day)  in the presence of fever salicylates bring down the temperature to normal.  In fever ,pyrogen increase the PGs synthesis in hypothalamus and disturbs the thermostat  Aspirin inhibit PGs synthesis and reset the temperature.  Increase the sweating and cutaneous vasodialation assist the antipyretic action
  • 12. 3.Anti-inflammatory action  At higher doses of 4-6g/day  It reduces the inflammatory signs like tenderness ,swelling ,erythema , and pain  But actually disease is progressing  In addition,Aspirin interfere with the formation of chemical mediators of kallilerin system.
  • 13. 4.Respiration  In therapeutic doses,it increase the consumption of O2 by skeltal muscles.→↑co2  It stimulates the respiratory center-→co2 washed out and leads to respiratory alkalosis and increase in pH→compensated by excretion of HCO3→known as compensated respiratory alkalosis  With toxic dose,direct stimulation of centres - Depression of respiratory center& cardiovascular centre→↑bp,respiratory acidosis,no compensations &metabbolic acidosis also-so called uncompensated respiratory acidosis  Renal failure
  • 14. 5.acid-base &electrolyte balance  In anti inflammatory dose ,it produce significant respiratory stimulation-co2 washed out resulting in respiratory alkalosis,pH become alkaline.  It compensated by secretion of HCO3+  In toxic doses produce respiratory acidosis  Effects accompanied by dehydration
  • 15. 6.Metabolic effect  Enhance the cellular metabolism due to uncoupling of oxidative phosphyration  More of o2 is used more co2 is produced ,leading to incresed heat production 7.GIT Aspirin blocks the PGs in stomach that leads to increase the hcl in stomach  Also salicylic acid increase HCl directly. This leads to peptic ulcer.  Also it affect CTZ and induce emesis
  • 16. ADVERSE EFFECT 1. GIT. Nausea ,epigastric distress,vomitting,erosive gastrirtis,peptic ulcer,increased occult blood loss in stools 2. CNS-headache,diziness 3. ALLERGIC REACTION 4. RESPIRATORY SYSTEM 5. HEMOLYSIS 6. NEPHROTOXICITY 7. REYE’S SYNDROME 8. PREGNANCY AND INFANCY 9. SALICYLISM
  • 17. ACUTE SALICYLATE INTOXICATION  Poisoning may be accidental or suicidal  More common in childrens  15-30 g is the fatal dose  Symptoms and signs- dehydration,hyoerpyrexia,GI irritation,vomitting,acid base imbalance,restlessness,deliriumhalucination,meta bolic acidosis,tremors,convulsions,coma,death due to resoiratory failure
  • 18.  TREATMENT-  Gastric lavage to eliminate unabsrobed drugs  Iv fluid to correct the acid base imbalance and dehydration  T is brouht down by external cooling with alcohole or cold water sponges  If hemorragic complications are seen ,blood transfusion and vit K are needed  In severe cases,forced alkaline diuresis with NaHCO3 and diuretic like frusemides is given along with iv fluid.
  • 19. PRECAUTION &CONTRAINDICATION 1. Peptic ulcer 2. Sensitive pt. 3. Children suffering from influenza &chickenpox 4. Chronic liver disease 5. Diabetics 6. Pregnancy-delayed labour,premature closure of ductus arterioles,bleeding 7. G6PD deficiency
  • 20. INTERACTION  Aspirin competes for pp sites and displacesdrug molecules resulting in toxicity like warfarin,heparin,naproxen,phenytoin  Inhibit the tubular scretion of uric acid and antogonizes the actions of uricosuric agent
  • 21. USES 1. As analgesics(300-400 mg/day in every 6-8 hrs) 2. Fever 3. For anti inflamatory conditions(4-6g/day) 4. Acute rheumatic fever(4-6g/day in 4-6 devided intrvl) 5. Rheumatoid arthritis 6. To delay labour 7. Prevention of colon cancer 8. PDA 9. Bartter s syndrom 10. Cataract 11. Osteoarthritis
  • 22. PARA-AMINOPHENOL DERIVATIVES  Eg;-paracetamol(acetoaminophen)  It has analgesics,antipyreticand weak anti- inflamatory properties  Uses-analgesics in painful condition like toothache,headache,myalgia  Used in chronic pulpitis,periodontal abcess,postextraction –used as combination  Adverse effect is hepatotoxic
  • 23. PYRAZOLONE DERIVATIVES  Eg;-phenylbutazone ,azapropazone,metamizol phenylbutazone  Good antiinflamatory and uricosuric agent  More toxic than aspirin  Uses are rheumatoid arthritis ,ankylosing spondylatis, gout,muskuloskeltal disorder  DOSE-100-200mg
  • 24. INDOLE DERIVATIVES  Eg:-indomethacine,sulindac,etodolac  It is a potent antiinflamatory agent ,antipyretic,and good analgesics  USES-1.rheumatoid arthrits 2.gout 3.closure of PDA 4.eye drops in inflamatoin 5.mouth rinsers in gingival inflammation  Side effects-CNS,GIT,and hyoersensitive reaction
  • 25. ARYLACETIC ACID DERIVATIVES Eg;-diclofenac,aciclofenac,keterolac  Aciclofenac-long acting ,more gastric friendly,COX2 selective  Used for acute musculoskeltal pain,painful dental lesions,post operatively for relief pain  Dose-100mg BD  Diclofenac-analgesics,antipyretics,and anti- inflamatory agent  Dose is 50 mg BD and gel are available for topical applications
  • 26. PROPONOIC ACID DERIVATIVES Eg:-Ibuprofen,naproxen,carprofen Ibuprofen  Analgesics,antipyretics,anti-inflamtory action  Acts by inhibits the PGs synthesis  Uses 1.Contol post surgical pain, 2.in fever 3.impacted tooth removal 4.gout.  Side effect -nausea ,vomitting,fluid retention,hypertensive reactionand gastric distress  Dose -400-800 mg TDS
  • 27.  NAPROXEN  Mode of action-NSAIDs reduces PGs activity.  Anti-inflamatory and antipyretic poperty  Contraindication-allergic pts.  Precaution-pts. With decreased renal function and liver function,heart failure or diuretic therapy can be risk for liver dysfunctionfluid retention while taking naproxen
  • 28. ANTHRANILIC ACIDS (FENAMATES) Eg;-flufenamic acid,mefenamic acid enfenamic acid  They are anagesics,antipyretic,antiinflamatory drugs  Contraindicated in children  They are not generally preferred  Diarrhea is common side effect  Mefenamic acid is used in dysmenorrhea(250- 500mg TDS)  Mefenamic acid exert peripheral and central analgesic action
  • 29. OXICAMS  EG;-piroxicam ,meloxicam  Piroxicam- Reversible cox inhibitor  Dose 20 mg OD  Used for rheumatoid arthritis ,osteoarthritis,painful dental lesions  Meloxicam-similar to piroxicam  Dose-7.5-15 mg once daily
  • 30. ALKANONES Eg;-nabumetone  It is antiinflamatory agent with significant efficacy in rheumatoid arthritis and osteoarthritis  Less uricogenic proprty  Used in rheumatoid and osteoarthritis
  • 31. SELECTIVE COX2 INHIBITORS  Eg;-celocoxib,rofecoxib,valdecoxib,etoricoxib  Celecoxib 100-200mg  Rofecoxib 12.5-25mg OD  Valdecoxib 20mg BD  Low uricogenic potential  Pedal edema &rise in BP occurs as result of salt and water retention due to the inhibition of consitutive COX2  Use for long term analgesics in chronic pain
  • 32. PREFERENTIAL COX2 INHIBITORS  Eg;-nimesulide  Used for short lasting painful conditions-sinusitis ,dental surgery ,backache , dysmenorrhea  Side effect-fuminant hepatitis -bronchospasm  Dose-50-100mg BD
  • 33. NSAIDS THAT DONOT INHIBIT PGs SYNTHESIS  Eg;-metamizol  analgin.,novalgin  Potent analgesics and antipyretics  Dose-500mg 3-4 times a day  Not recommended in childresns upto 6 years
  • 34. REFERENCE  TEXT BOOK OF PHARMOCOLOGY -TRIPATI  TEXT BOOK OF ORAL AND MAXILLOFACIAL SURGERY - SM BALAJI TEXT BOOK OF DENTAL PHARMACOLOGY - PADMAJA UDAYAKUMAR